Current
Neuro-Oncology

Volume 18 Number 3
31 March 2016

Home > Publications > Current Neuro-Oncology > Volume 18, Year 2016 > Number 3, 31 March

Franceschi E, Depenni R, Paccapelo A, Ermani M, Faedi M, Sturiale C, Michiara M, Servadei F, Pavesi G, Urbini B, Pisanello A, Crisi G, Cavallo MA, Dazzi C, Biasini C, Bertolini F, Mucciarini C, Pasini G, Baruzzi A, Brandes AA; PERNO Study Group.
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.
J Neurooncol. 2016 Mar 4, 2016;128(1):157-162→. doi: 10.1007/s11060-016-2093-1→. PMID: 26943851→. Interventional study. ˍ

*

Brandes AA, Finocchiaro G, Zagonel V, Reni M, Caserta C, Fabi A, Clavarezza M, Maiello E, Eoli M, Lombardi G, Monteforte M, Proietti E, Agati R, Eusebi V, Franceschi E.
AVAREG: a phase 2, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma.
Neuro Oncol. 2016 Mar 6, 2016;18(9):1304-12→. doi: 10.1093/neuonc/now035→. PMID: 26951379→. Interventional study. ˍ

Chamberlain MC.
Standard chemoradiation for glioblastoma results in progressive brain volume loss.
Neurology. 2016 Mar 7, 2016;86(10):979→. doi: 10.1212/01.wnl.0000481823.96137.39→. PMID: 26952303→. Comment. ˍ
Refers to: Prust MJ, et al.,Standard chemoradiation for glioblastoma results in progressive brain volume loss.
Neurology. 2015 Jul 24, 2015;85(8):683-91→. doi: 10.1212/WNL.0000000000001861→. PMID: 26208964→. Observational study. ˍ
Author’s reply. Dietrich J, Prust M. Author Response.
Neurology. 2016 Mar 7;86(10):979[No link]. PMID: 27390802→.

Hernández Cancela RM, Pombo Otero J, Concha-Lopez A.
A case of multifocal medulloblastoma in an adult patient.
Rev Esp Patol. 2016 Mar 8, 2017;50(1):45-48→. doi: 10.1016/j.patol.2015.12.005→. PMID: 29179964→. Case report. ˍ

Igala M.
Unusual relapse of primary central nervous system lymphoma.
Springerplus. 2016 Mar 9;5:301→. doi: 10.1186/s40064-016-1926-x→. PMID: 27066337→. Case report. ˍ

Sharma R, D'Souza M, Jaimini A, Hazari PP, Saw S, Pandey S, Singh D, Solanki Y, Kumar N, Mishra AK, Mondal A.
A comparison study of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography-computed tomography scans in evaluation of patients with recurrent brain tumors.
Indian J Nucl Med. 2016 Mar 9, 2016;31(2):93-102→. doi: 10.4103/0972-3919.178254→. PMID: 27095856→. Observational study. ˍ

Bilqees F, Samina K, Mohammad T, Khaleeq-uz-Zamaan.
Morphological pattern and frequency of central nervous system tumours in children.
J Ayub Med Coll Abbottabad. 2016 Mar 10, 2016;28(1):44-6→. PMID: 27323560→. Observational study. ˍ

Krishnatry R, Zhukova N, Guerreiro Stucklin AS, Pole JD, Mistry M, Fried I, Ramaswamy V, Bartels U, Huang A, Laperriere N, Dirks P, Nathan PC, Greenberg M, Malkin D, Hawkins C, Bandopadhayay P, Kieran MW, Manley PE, Bouffet E, Tabori U.
Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
Cancer. 2016 Mar 10, 2016;122(8):1261-9→. doi: 10.1002/cncr.29907→. PMID: 26970559→. Observational study. ˍ

Herrlinger U, Schäfer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Friedrich F, Rohde V, Ringel F, Schlegel U, Sabel M, Ronellenfitsch MW, Uhl M, Maciaczyk J, Grau S, Schnell O, Hänel M, Krex D, Vajkoczy P, Gerlach R, Kortmann RD, Mehdorn M, Tüttenberg J, Mayer-Steinacker R, Fietkau R, Brehmer S, Mack F, Stuplich M, Kebir S, Kohnen R, Dunkl E, Leutgeb B, Proescholdt M, Pietsch T, Urbach H, Belka C, Stummer W, Glas M.
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.
J Clin Oncol. 2016 Mar 14, 2016;34(14):1611-9→. doi: 10.1200/JCO.2015.63.4691→. PMID: 26976423→. Interventional study. ˍ

Jia A, Pannullo SC, Minkowitz S, Taube S, Chang J, Parashar B, Christos P, Wernicke AG.
Innovative Hypofractionated Stereotactic Regimen Achieves Excellent Local Control with No Radiation Necrosis: Promising Results in the Management of Patients with Small Recurrent Inoperable GBM.
Cureus. 2016 Mar 17;8(3):e536→. doi: 10.7759/cureus.536→. PMID: 27096136→. Observational study. ˍ

Tamayo-Orrego L, Wu CL, Bouchard N, Khedher A, Swikert SM, Remke M, Skowron P, Taylor MD, Charron F.
Evasion of Cell Senescence Leads to Medulloblastoma Progression.
Cell Rep. 2016 Mar 17. 2016;14(12):2925-37→. doi: 10.1016/j.celrep.2016.02.061→. PMID: 26997276→. Laboratory investigation. ˍ

Matsumoto H, Yoshida Y.
De novo cerebellar malignant glioma: A case report.
Int J Surg Case Rep. 2016 Mar 18, 2016;22:28-31→. doi: 10.1016/j.ijscr.2016.03.020→. PMID: 27017277→. Case report. ˍ

Gilbert MR.
Antiangiogenic Therapy for Glioblastoma: Complex Biology and Complicated Results.
J Clin Oncol. 2016 Mar 21, 2016;34(14):1567-9→. doi: 10.1200/JCO.2016.66.5364→. PMID: 27001588→. Editorial. ˍ
Refers to: Herrlinger U, et al., Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.
J Clin Oncol. 2016 Mar 14, 2016;34(14):1611-9→. doi: 10.1200/JCO.2015.63.4691→. PMID: 26976423→. Interventional study. ˍ

Kumar RM, Finn M.
Primary Multifocal Gliosarcoma of the Spinal Cord.
Rare Tumors. 2016 Mar 21;8(1):6102→. doi: 10.4081/rt.2016.6102→. PMID: 27134708→. Case report. ˍ

Chinot OL, Nishikawa R, Mason W, Henriksson R, Saran F, Cloughesy T, Garcia J, Revil C, Abrey L, Wick W.
Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio.
Neuro Oncol. 2016 Mar 22, 2016;18(9):1313-8→. doi: 10.1093/neuonc/now046→. PMID: 27006178→. Interventional study. ˍ

Jakacki RI, Cohen KJ, Buxton A, Krailo MD, Burger PC, Rosenblum MK, Brat DJ, Hamilton RL, Eckel SP, Zhou T, Lavey RS, Pollack IF.
Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.
Neuro Oncol. 2016 Mar 22, 2016 Oct;18(10):1442-50→. doi: 10.1093/neuonc/now038→. PMID: 27006176→. Interventional study. ˍ

Lulla RR, Goldman S, Yamada T, Beattie CW, Bressler L, Pacini M, Pollack IF, Fisher PG, Packer RJ, Dunkel IJ, Dhall G, Wu S, Onar A, Boyett JM, Fouladi M.
Phase 1 trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study.
Neuro Oncol. 2016 Mar 28, 2016;18(9):1319-25→. doi: 10.1093/neuonc/now047→. PMID: 27022131→. Interventional study. ˍ

Pitter KL, Tamagno I, Alikhanyan K, Hosni-Ahmed A, Pattwell SS, Donnola S, Dai C, Ozawa T, Chang M, Chan TA, Beal K, Bishop AJ, Barker CA, Jones TS, Hentschel B, Gorlia T, Schlegel U, Stupp R, Weller M, Holland EC, Hambardzumyan D.
Corticosteroids compromise survival in glioblastoma.
Brain. 2016 Mar 28, 2016;139(Pt 5):1458-71→. doi: 10.1093/brain/aww046→. PMID: 27020328→. Observational study. ˍ

Rennert RC, Achrol AS, Januszyk M, Kahn SA, Liu TT, Liu Y, Sahoo D, Rodrigues M, Maan ZN, Wong VW, Cheshier SH, Chang SD, Steinberg GK, Harsh GR, Gurtner GC.
Multiple Subsets of Brain Tumor Initiating Cells Coexist in Glioblastoma.
Stem Cells. 2016 Mar 28, 2016;34(6):1702-7→. doi: 10.1002/stem.2359→. PMID: 26991945→. Laboratory investigation. ˍ

Malkki H.
Neuro-oncology: Long-term outcomes in childhood low-grade glioma.
Nat Rev Neurol. 2016 Mar 29, 2016;12(4):188→. doi: 10.1038/nrneurol.2016.42→. (No PMID). Comment. ˍ
Refers to: Krishnatry R, et al.,Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
Cancer. 2016 Mar 10, 2016;122(8):1261-9→. doi: 10.1002/cncr.29907→. PMID: 26970559→. Observational study. ˍ

Malkki H.
Trial Watch: Glioblastoma vaccine therapy disappointment in Phase III trial.
Nat Rev Neurol. 2016 Mar 29, 2016;12(4):190→. doi: 10.1038/nrneurol.2016.38→. PMID: 27020557→. Comment. ˍ
Refers to: Weller M et al., Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Lancet Oncol. 2017 Aug 22, 2017;18(10):1373-1385→. doi: 10.1016/S1470-2045(17)30517-X→. PMID: 28844499→. Interventional study. ˍ

Adeberg S, Bernhardt D, Harrabi SB, Diehl C, Koelsche C, Rieken S, Unterberg A, von Deimling A, Debus J.
Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
J Neurooncol. 2016 Mar 30, 2016;128(2):341-8→. doi: 10.1007/s11060-016-2117-x→. PMID: 27025857→. Observational study. ˍ

Buglione M, Pedretti S, Poliani PL, Liserre R, Gipponi S, Spena G, Borghetti P, Pegurri L, Saiani F, Spiazzi L, Tesini G, Uccelli C, Triggiani L, Magrini SM.
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed?
J Neurooncol. 2016 Mar 30, 2016;128(2):303-12→. doi: 10.1007/s11060-016-2112-2→. PMID: 27025858→. Observational study. ˍ

Tsutsui T, Miyashita K, Sabit H, Fukui I, Hayashi Y, Mizokami A, Ikeda H, Nagatani H, Nakada M.
Acute Progression of Recurrent Meningioma during Luteinizing Hormone-Releasing Hormone Agonist Treatment for Prostate Cancer.
World Neurosurg. 2016 Mar 30, 2016;91:670.e1-6→. doi: 10.1016/j.wneu.2016.03.076→. PMID: 27046016→. Case report. ˍ

Heng MA, Padovani L, Dory-Lautrec P, Gentet JC, Verschuur A, Pasquier E, Figarella-Branger D, Scavarda D, André N.
Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab-irinotecan in children with low-grade glioma?
Cancer Med. 2016 Mar 31, 2016;5(7):1542-5→. doi: 10.1002/cam4.699→. PMID: 27037940→. Observational study. ˍ

Trubicka J, Szperl M, Grajkowska W, Karkucińska-Więckowska A, Tarasińska M, Falana K, Dembowska-Bagińska B, Łastowska M.
Identification of a novel inherited ALK variant M1199L in the WNT type of medulloblastoma.
Folia Neuropathol. 2016 Mar 31, 2016;54(1):23-30→. doi: 10.5114/fn.2016.58912→. PMID: 27179218→. Laboratory investigation. ˍ